(Q45134478)

English

The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression

scientific article published in January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

author name string

Szegedi A

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Rujescu D

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Tadic A

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Müller MJ

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Kohnen R

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Stassen HH

6

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Dahmen N

7

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

The Pharmacogenomics Journal

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

49-53

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

21 January 2018

Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

21 January 2018

Moclobemide response in depressed patients: association study with a functional polymorphism in the monoamine oxidase A promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

21 January 2018

Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

21 January 2018

SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

21 January 2018

A Review of the Pharmacological and Clinical Profile of Mirtazapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

21 January 2018

Presynaptic adrenergic receptor sensitivity in depression. The effect of long-term desipramine treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

21 January 2018

Locus coeruleus neuronal activity and noradrenaline availability in the frontal cortex of rats chronically treated with imipramine: effect of alpha 2-adrenoceptor blockade.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

21 January 2018

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

21 January 2018

The Relationship between COMT Genotype and the Clinical Effectiveness of Tolcapone, a COMT Inhibitor, in Patients with Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

21 January 2018

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

7 January 2021

based on heuristic

inferred from DOI database lookup

Serotonin transporter gene polymorphism and antidepressant response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

7 January 2021

based on heuristic

inferred from DOI database lookup

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

7 January 2021

based on heuristic

inferred from DOI database lookup

Genotypes of catechol-O-methyltransferase and response to levodopa treatment in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

7 January 2021

based on heuristic

inferred from DOI database lookup

Mirtazapine compared with paroxetine in major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.TPJ.6500289

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45134478&oldid=2207112983"